BIRC2 Expression Impairs Anti-Cancer Immunity and Immunotherapy Efficacy
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 32 (8) , 108073
Abstract
No abstract availableKeywords
Funding Information
- Susan G. Komen
- American Cancer Society
This publication has 55 references indexed in Scilit:
- Hypoxia-Inducible Factor 1 and Cardiovascular DiseaseAnnual Review of Physiology, 2014
- Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signalingBreast Cancer Research and Treatment, 2013
- The UCSC Cancer Genomics Browser: update 2013Nucleic Acids Research, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Towards a knowledge-based Human Protein AtlasNature Biotechnology, 2010
- Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metageneBritish Journal of Cancer, 2010
- RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationProceedings of the National Academy of Sciences, 2009
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006